BTSG (BrightSpring Health Services) Research & Development: $0 Mil (TTM As of Mar. 2026)


BTSG BrightSpring Health Services Inc BTSG
40 GF Score
Price $67.61
! 7 Warning Signs
View Full Analysis

What is BrightSpring Health Services Research & Development?

BrightSpring Health Services BTSG +1.19% 40 Research & Development is $0 Mil as of Mar. 2026. GuruFocus rates BTSG with a GF Score™ of 40/100. The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. BrightSpring Health Services's Research & Development for the three months ended in Mar. 2026 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0 Mil.

BrightSpring Health Services  (NAS:BTSG) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

BrightSpring Health Services Research & Development Related Terms

BrightSpring Health Services Research & Development Historical Data

* Premium members only.

The historical data trend for BrightSpring Health Services's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BrightSpring Health Services Research & Development Chart

BrightSpring Health Services Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

BrightSpring Health Services Quarterly Data
Sep20 Dec20 Jun21 Sep21 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BTSG
40GF Score
BrightSpring Health Services Inc BTSG
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BrightSpring Health Services Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
BrightSpring Health Services (BTSG) has a Research & Development of $0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on BrightSpring Health Services and its competitors.
Is BrightSpring Health Services' Research & Development too high?
BrightSpring Health Services' current Research & Development is $0 Mil. Overall, BrightSpring Health Services has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does BrightSpring Health Services' Research & Development compare to TEM and HQY?
BrightSpring Health Services' Research & Development of $0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on BrightSpring Health Services and its competitors. BrightSpring Health Services's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BrightSpring Health Services stock overvalued right now?
BrightSpring Health Services (BTSG) has a current Research & Development of $0 Mil. The current Research & Development is $0 Mil. BrightSpring Health Services' overall GF Score™ is 40/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For BrightSpring Health Services (BTSG), the current Research & Development is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BrightSpring Health Services Business Description

Address 805 N. Whittington Parkway, Louisville, KY, USA, 40222
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Services, and others. It generates the majority of its revenue from the Pharmacy Solutions segment.
40GF Score

Get the complete analysis for BTSG

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$67.61
Price